Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Connect Biopharma Holdings (CNTB) Interest & Investment Income (2024 - 2025)

Connect Biopharma Holdings' Interest & Investment Income history spans 2 years, with the latest figure at $545000.0 for Q3 2025.

  • For Q3 2025, Interest & Investment Income fell 51.98% year-over-year to $545000.0; the TTM value through Sep 2025 reached $2.7 million, changed N/A, while the annual FY2024 figure was $4.5 million, 14.74% down from the prior year.
  • Interest & Investment Income for Q3 2025 was $545000.0 at Connect Biopharma Holdings, down from $619000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $1.2 million in Q1 2024 and bottomed at $545000.0 in Q3 2025.